This online medical resource for scientific and clinical information is intended to share the latest development in clinical research on GSK Products
The GSK medical affairs portal is designed exclusively for healthcare professionals. This webpage gives and overview of our latest research on prevention through vaccination of herpes zoster
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas rhoncus augue nunc, quis consectetur tortor malesuada at curabitur. Dolor sit amet, consectetur adipiscing elit. Maecenas rhoncus aug nunc, quis consectetur tortor malesuada at curabitur.
Solicite la visita de uno de nuestros delegados de GSK- Confirmación
Contacte con el centro de información, solicite la visita de un delegado o el contacto por el departamento médico, Notifique de una sospecha de reacción adversa
GSK is a global healthcare company that presents at oncology conferences to showcase its newest products and posters. Their presentations are informative, inspiring, and insightful, helping audiences understand GSK's innovations for cancer treatment. #GSK #Oncology #Conferences #Cancer #Treatment #Research #MedicalAffairs
Our unique R&D approach of Science x Technology x Culture is helping to fight cancer on multiple groundbreaking fronts – focusing on maximizing survival through the discovery and development of novel oncology medicines that may have life-changing potential.
While RSV-related infections usually present as mild cold-like symptoms in adults, some cases may lead to more serious respiratory complications, hospitalization and death, particularly in older adults and those with underlying conditions1
Respiratory syncytial virus (RSV) is an important cause of respiratory illness in all ages, including vulnerable adults. Learn about RSV and the associated disease in adults.1
Treatment options for herpes zoster are suboptimal and may have limited efficacy and poor tolerability in some patients. Therefore, improvements are needed in the prevention and management of herpes zoster.1,2
The GSK medical affairs portal is designed exclusively for healthcare professionals. This webpage gives and overview of our latest research on Burden of disease and complications of herpes zoster
The GSK medical affairs portal is designed exclusively for healthcare professionals. This webpage gives and overview of our latest research on epidemiology and risk factors of herpes zoster
Herpes zoster, also known as shingles, is a painful condition caused by reactivation of the varicella zoster virus, the same virus that causes chickenpox.1-4
View disease information content from GSK Vaccines
This webpage is intended as a medical ressource for scientific and clicnical information to support HCP's in understanding vaccinology and share information on GSK researches and candidate vaccines
The latest information on vaccines, treatments, and other medical advances in the field of healthcare at upcoming medical congresses where GSK is present. #vaccines #congresses #medical #HCPs
Strengthening our R&D pipeline through a focus on science related to the immune system, the use of the human genetics, and advanced technologies
Efficacy, immunogenicity, and safety of the adjuvanted recombinant zoster vaccine (RZV) in immunocompromised subjects
View videos from GSK oncology on mechanism of disease as well as other disease education resources.
This area of the website is intended for HCPs specializing in Oncology. GSK does not support or endorse any use of its products that is not consistent with the approved prescribing information in the official product monograph
Throughout life, vaccines are recommended to protect individuals from vaccine-preventable diseases.